Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Melissa A. Chapaska and Judith D. Cassel of Cannibis Law PA in Harrisburg

Because marijuana is still frustratingly and inappropriately listed on Schedule 1 of the Controlled Substance Act (21 U.S.C. Section  321 et seq.) the federal rules applicable to labeling pharmaceuticals do not really apply to medical marijuana. The lack of safe and uniform labeling standards is just another casualty of the federal government’s placement of marijuana on the same schedule as drugs such as heroin, LSD and Ecstasy. Marijuana’s categorization as a Schedule 1 controlled substance has also created challenges for medical marijuana entities seeking to develop informed consent and disclaimers to minimize liabilities arising from any adverse effects experienced by patients. Physicians, grower/processors, and dispensary operators (participants) have therefore made varied attempts to try to properly inform patients of potential risks using labeling and informed consent forms.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.